Carelon Research launches new real-world data offering to support healthcare evidence generation

Carelon Research is proud to launch access to Carelon Real World Data, our integrated, analysis-ready data, complete with patient, provider, and payer information, for valuable insights and context for life sciences research and real-world evidence generation.

As life sciences teams target new therapeutic areas, new indications, and novel pricing models, high quality real-world data has tremendous value.

Carelon Real World Data is a comprehensive, analysis-ready dataset for research, curated straight from the source, delivered with hands-on service. It includes:

• Pharmacy and medical closed claims linked with electronic health records (EHR) 
• Enrollment records since 2006
• Commercial and Medicare populations
• Enhanced oncology data
• Laboratory results, standardized cost data, race and ethnicity data, social determinants of health (SDOH) data

“Data drives impactful evidence generation that, in turn, advances healthcare and the health of humanity,” said Mark Cziraky , Vice President, Elevance Health & President, Carelon Research. “Today, we’re empowering our life sciences partners to generate insights with direct access to this robust real-world data from one of the nation’s largest health insurance data environments.”

An analysis-ready dataset built on 25 years of research heritage and data governance

With direct connectivity to the data source, Carelon Research (formerly HealthCore) has continuously refined this dataset and its governance through nearly three decades of research. We share this expertise with clients, supporting accurate interpretation of our data and as partners in their own research.

Carelon Real World Data draws from the Healthcare Integrated Research Database (HIRD), our proprietary database of Commercial and Medicare populations. The HIRD has supported more than 3,000 publications, including randomized clinical trials, health economics and outcomes research, safety and epidemiology, prospective observational research designs, pragmatic clinical trials and other patient-centered research.

“There’s something special about a dataset built for research,” said Ozgur Tunceli , Principal Scientist, Carelon Research. “Having worked with this data for more than 20 years and used it in support of a large portfolio of real-world evidence and research, I’m eager to see the progress our clients make as they work with it directly.”

Data tailored for Medical Affairs and Real-World Evidence, Market Access, Commercialization, and Pharmacovigilance

Clients can access Carelon Real World Data tailored with available data elements for specific needs such as date of death, race and ethnicity, or provider identification (NPI), added to two core datasets:

• Pan-therapeutic data focused on patients and treatments in all therapeutic areas, with linked claims and EHR data for valuable context into patient journeys
• Oncology-specific data focused on oncology patients and treatments

Carelon Real World Data is supported by leading research and therapeutic area experts from behavioral health to oncology. Dedicated client success teams help clients understand our data as well as we do, rooted in our own research heritage.

Explore more complete, granular insights

Qualified clients can explore a sample of Carelon Real World Data.